We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Novatek

News List

Novatek Seeks EUA for TQ Formula to Treat COVID ContractPharma
November 02, 2021
Novatek Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company, announced topline results from a Phase 2 randomized, controlled multicenter trial...
Novatek seeks FDA authorisation for oral drug to treat Covid-19 Pharmaceutical-Technology
November 02, 2021
Novatek Pharmaceuticals has sought emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its oral TQ Formula to treat Covid-19-infected individuals in the outpatient setting.
Novatek seeks EUA after its Oral TQ Formula Significantly improved Total Symptom Burden in a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of COVID-19 Patients in the Outpatient Setting prnewswire
November 02, 2021
Novatek Pharmaceuticals, Inc. ("Novatek") a privately held, clinical-stage biopharmaceutical company today announced topline results from a Phase 2 randomized, controlled multicenter trial (BOSS-Covid-19 study)...
Novatek Requalified as Supplier for Boehringer Aseptic Mfg. Facilities contractpharma
May 27, 2021
Novatek's regulatory compliant quality solutions used at Boehringer for human pharma, animal health and biopharmaceutical sterile manufacturing sites.